As was confirmed by the company on Monday, Affymetrix Inc. and its partner TessArae have managed to win emergency approval from the US Food and Drug Administration to market their swine flu test that the firms claim can correctly identify the presence of a H1N1 virus with a single test.
The TessArray RM-Flu test was developed in association with Affymetrix, using the latter's GeneChip technology. The emergency approval will last till the declared swine flu emergency comes to an end. Currently, the end date is pegged at April 26, 2010.
As confirmed by the company, the test is administered on throat swabs which are taken from patients who are experiencing respiratory infection symptoms.
Post the announcement, shares of Affymetrix, which is involved in manufacturing of arrays to analyze genetic data, managed to climb by 3% to $5.71.
Popular content
Today's:
All time:
Last viewed:
- AT&T to Offer Motorola Backflip for $99, 2 Year Contract
- NY AG’s office seeks ‘more details’ from Bank of America on Merrill deal
- Blue Cross agrees to $1 million settlement of lawsuit over denied claims
- Charlie and Wife in a Massive Fight
- Natural-Gas Corporations Drilling More Wells even as Price falls
- Low interest rates in US cause dollar speculation: Liu Mingkang
- Korean Deal Good for LNG
- Investment banking firm Lane Berry acquired by Raymond James Financial
- Apple releases iPhone update
- ‘Cash-flow positive’ startup Animoto raises $4.4 million funding round
